-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
With the global outbreak of the new crown pneumonia epidemic, the demand for ventilators, an important medical equipment used for epidemic prevention and control, has surged, and overseas countries are facing a large supply gap, and they have been searching for ventilators around the world
.
Medtronic: Double ventilator capacity and supply
Medtronic: Double ventilator capacity and supplyMedtronic recently announced that it will double its own ventilator production capacity and supply to meet the urgent needs of patients and medical systems around the world amid the new coronavirus outbreak
.
Medtronic, which manufactures both the PB840 and PB980 ventilators in Galway, Ireland, are used for the treatment of critically ill patients, and in recent weeks, Medtronic has doubled its usual production shifts for the PB980 and PB840 ventilators and is looking for opportunities to further increase capacity
.
"Medtronic understands that the demand for ventilators is far greater than the supply," said Bob White, executive vice president and president of the Minimally Invasive Therapies business group at Medtronic
.
In addition, Medtronic has also discussed with Tesla about cooperating in the production of ventilators.
Tesla said on social media Twitter on March 22 that it had smooth talks with Medtronic, a medical equipment manufacturer, on the production of ventilators, aiming to solve the problems caused by the epidemic.
caused by the shortage of ventilators
.
GE: Ventilators to double again by end of second quarter
GE: Ventilators to double again by end of second quarterSince the COVID-19 outbreak, GE Healthcare has doubled production of ventilators and plans to double it again by the end of the second quarter of this year (non-Ford partner equipment) to meet urgent demand in the global market
.
In Italy, the overseas country most severely affected by the new crown pneumonia epidemic, Antonio Spera, business manager of GE Healthcare, and his team are fighting at the forefront of the epidemic
.
Spera has a team of 200 engineers and technicians who provide hospitals with ventilators, imagers, monitors and other technical equipment
.
Antonio Spera, business manager at GE Healthcare
Currently, GE is working with local governments and non-profit organizations in Italy to provide medical staff with equipment
.
Spera and his team suspended some of their daily work to begin installing much-needed equipment at the hard-hit hospital
.
In addition to equipment installation, GE's engineers and technicians also conduct appropriate training for equipment users
.
To keep employees safe, GE has doubled the number of employees offering remote services
.
The use of remote monitoring software and tools not only allows engineers to remotely troubleshoot machines, but even enables imaging systems to be restarted in the kitchen at home, avoiding unnecessary risks
.
In addition, according to the requirements of the U.
S.
Food and Drug Administration (FDA), GE Healthcare has published information on the use of GE anesthesia equipment to mechanically ventilate patients on its official global website, supporting clinicians to treat more respiratory failure or respiratory failure.
Difficult COVID-19 patients
.
Aion Medical: Overseas orders surge, thousands of ventilators are urgently scheduled for production
Aion Medical: Overseas orders surge, thousands of ventilators are urgently scheduled for productionBeijing Aion Medical System Co.
, Ltd.
(hereinafter referred to as Aion Medical), founded in 2001, is a leading enterprise in the R&D and manufacturing of anesthesia and respiratory medical equipment in China
.
Since the outbreak of the global epidemic, Aeon Medical has successively received urgent procurement projects of ventilators from 35 countries and regions including Italy, the United Kingdom, Germany, Russia, Serbia, Rwanda, Ukraine, and Mongolia
.
So far, Aeon Medical has produced and delivered more than 1,000 ventilators to the international market, and several thousand more ventilators are in urgent production
.
Earlier, Serbian President Vucic delivered a televised speech, announcing that Serbia immediately entered a state of emergency, and at a press conference in front of the media, he cried for help from China
.
Aion Medical's first batch of 145 ventilators arrived in Belgrade, the capital of Serbia, on the morning of March 26, local time
.
The ventilators sent to Serbia this time are mainly the emergency transport ventilator Shangrila510S and the therapeutic ventilator VG70
.
In the treatment of new coronary pneumonia, these two ventilators can provide a full range of treatment methods for patients with new coronary pneumonia
.
Shangrila510S ventilator can be used for pre-hospital emergency treatment, intra-hospital and inter-hospital emergency transport, and is suitable for different scenarios such as emergency room and ward
It is worth mentioning that the Shangrila 510S respiratory workstation customized for COVID-19 will provide better portability and therapeutic effect for clinical use
.
Currently this Shangrila510S respiratory workstation is mass-produced to meet demands from all over the world
.
Yuyue Medical: The daily limit production capacity will reach 700 units by the end of April
Yuyue Medical: The daily limit production capacity will reach 700 units by the end of AprilAccording to the Financial Associated Press, Yuyue Medical is also urgently producing ventilators to meet the needs of foreign epidemics
.
The factory's production equipment operates 24 hours a day, especially in the production workshop of anti-epidemic products
.
It is reported that due to the impact of the epidemic, orders for anti-epidemic products such as ventilators in foreign countries have increased significantly recently, and Yuyue Medical's non-invasive ventilator collection orders have been placed until the end of April
.
Yuyue BreathCareⅡ Series Ventilator
According to the epidemic situation, Yuyue Medical will give priority to delivery to foreign regions with severe epidemic situation
.
At the same time, anti-epidemic products such as disinfectants and forehead thermometers completed the production of the past 10 years in two months
.
In addition, after the previous domestic anti-epidemic production training, there are not too many obstacles in the cooperation between Yuyue Medical and the industrial chain
.
At present, the daily limit production capacity of ventilators can reach 700 units
.
Further reading
Further readingMajor medical device companies export medical resources to help fight the epidemic
Major medical device companies export medical resources to help fight the epidemicIn addition to ventilators, major medical device companies have also disclosed that they have received a large number of overseas orders for other types of medical devices.
According to Mindray Medical, Italy has urgently purchased the first batch of nearly 10,000 anti-epidemic equipment from Mindray, including ventilators and monitors.
Waiting for medical equipment, Mindray will deliver it in batches in an orderly manner
.
Mindray's SV300 is the first electric turbine ventilator in China, and it is the crystallization of the collaborative research of R&D teams in China, Northern Europe and North America.
Guangdong Biolight Medical Technology Co.
, Ltd.
said it received an urgent order from Italy for 1,000 high-end monitors
.
Shenzhen Libang Precision Instrument Co.
, Ltd.
Libang Instrument said that it has received orders for more than 20 blood gas products
.
The domestic gene sequencing company BGI, and the temperature measurement companies AutoNavi, Dali Technology and Golden Shield have all disclosed that they have received more overseas orders
.
Among them, BGI said that at present, orders for the kits have covered 70 countries and regions, and have been shipped to Japan, Brunei, Thailand, the United Arab Emirates, Egypt, Peru and other places
.
"We have obtained the US FDA's emergency use authorization for the COVID-19 test kit, which will help provide high-quality, high-throughput testing services in the United States.
The results of nucleic acid testing can help medical professionals respond quickly and assist in the new coronavirus infection.
to prevent the further spread of infection,
” said Yin Ye, CEO of BGI
.
With the global shortage of resources for epidemic prevention and control, Chinese medical device companies have gone all out to export medical resources to help prevent and control the epidemic
.